Detalles de la búsqueda
1.
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program.
Pituitary
; 24(4): 611-621, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709288
2.
An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies.
Pituitary
; 23(4): 347-358, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32221764
3.
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ.
Pituitary
; 22(6): 581-593, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31522359
4.
A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.
Pituitary
; 20(6): 605-618, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28741071
5.
Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.
Pituitary
; 20(4): 422-429, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28275992
6.
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
Endocr Pract
; 23(8): 962-970, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28614003
7.
Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.
Pituitary
; 19(3): 332-41, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26897383
8.
TRENDS IN GROWTH HORMONE STIMULATION TESTING AND GROWTH HORMONE DOSING IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: RESULTS FROM THE ANSWER PROGRAM.
Endocr Pract
; 22(4): 396-405, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26574788
9.
Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY.
Endocr Pract
; 21(3): 264-74, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25370326
10.
Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.
Pituitary
; 17(1): 13-21, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23314980
11.
Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.
Pituitary
; 16(2): 220-30, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22806554
12.
Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies.
Endocr Connect
; 12(1)2023 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36347049
13.
Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER.
J Endocr Soc
; 7(6): bvad054, 2023 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37197408
14.
ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly.
J Clin Endocrinol Metab
; 108(5): e148-e159, 2023 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36353760
15.
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
Front Endocrinol (Lausanne)
; 13: 899616, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35574017
16.
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial.
Lancet Diabetes Endocrinol
; 10(2): 102-111, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953531
17.
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
Front Endocrinol (Lausanne)
; 12: 662865, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34335465
18.
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands.
Front Endocrinol (Lausanne)
; 12: 627711, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33790860
19.
RECURRENT INVASIVE DUCTAL BREAST CARCINOMA PRESENTING AS PRIMARY ADRENAL INSUFFICIENCY WITH ADRENAL CRISIS.
AACE Clin Case Rep
; 6(2): e50-e53, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32524010
20.
Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations.
Clin Diabetes Endocrinol
; 6(1): 18, 2020 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33292727